Anuh Pharma Ltd - 506260 - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Anuh Pharma applied to stock exchanges for reclassification of certain persons from the Promoter Group to the Public category. This involves 0.95% of total shares.
May 25 2026 23:28:39
Anuh Pharma Ltd - 506260 - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Anuh Pharma's Board approved the re-classification of 0.94% of its promoter group shareholding to the public category. This move aligns with SEBI Regulation 31A, as the shareholders are not involved in the company's management or operations.
May 22 2026 19:09:54
Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Adoption For Policy For Implementation Of NFRA Circular
Anuh Pharma's Board approved the re-classification of specific promoter group shareholders, representing 0.95% of total shareholding, to the public category. This change is subject to approval from the company's shareholders at the upcoming AGM.
May 20 2026 23:55:04
Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Appointment Of Scrutinizer For The 66Th Annual General Meeting.
Anuh Pharma's Board approved the re-classification of specific promoter group shareholders, representing 0.95% of total shareholding, to the public category. This change is subject to approval from the company's shareholders at the upcoming AGM.
May 20 2026 23:51:08
Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - 66Th Annual General Meeting Will Be Held On Wednesday, 12Th August, 2026.
Anuh Pharma's Board approved the re-classification of specific promoter group shareholders, representing 0.95% of total shareholding, to the public category. This change is subject to approval from the company's shareholders at the upcoming AGM.
May 20 2026 23:47:21
Anuh Pharma Ltd - 506260 - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Anuh Pharma's Board approved the re-classification of specific promoter group shareholders, representing 0.95% of total shareholding, to the public category. This change is subject to approval from the company's shareholders at the upcoming AGM.
May 20 2026 23:38:01
Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination Of Materiality Of Events.
Anuh Pharma's board approved the audited financial results for FY26 and recommended a final dividend. Additionally, the board adopted new Memorandum and Articles of Association and reclassified 0.95% of shares from the promoter to the public category.
May 20 2026 23:29:52
Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Adoption Of Memorandum Of Association (MOA) And Articles Of Association (AOA) As Per Companies Act, 2013
Anuh Pharma's Board approved audited financial results for FY26 and recommended a final dividend of Rs. 1.50 per equity share. The record date for the dividend is August 5, 2026, and the AGM will be held on August 12, 2026.
May 20 2026 23:25:01
Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Appointment Of Internal Auditor.
Anuh Pharma's board approved audited financial results for FY26, reporting Rs. 771.66 cr revenue (up 16.65% YoY) and Rs. 41.05 cr PAT (down 13.31% YoY). A final dividend of Rs. 1.50 per equity share was recommended, with August 5, 2026, as the record date.
May 20 2026 23:04:52
Anuh Pharma Ltd - 506260 - Announcement Under Regulation 30 (LODR) - Appointment Of Mr. P.N. Rao As General Manager - Quality
Anuh Pharma's Board approved audited financial results for FY26 and recommended a final dividend of Rs. 1.50 per equity share. The record date for the dividend is August 5, 2026, and the AGM will be held on August 12, 2026.
May 20 2026 23:02:30
Read More